GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioptik Technology Inc (ROCO:4161) » Definitions » Gross-Profit-to-Asset %

Bioptik Technology (ROCO:4161) Gross-Profit-to-Asset % : 17.26% (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Bioptik Technology Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Bioptik Technology's annualized Gross Profit for the quarter that ended in Mar. 2025 was NT$255.2 Mil. Bioptik Technology's average Total Assets over the quarter that ended in Mar. 2025 was NT$1,478.5 Mil. Therefore, Bioptik Technology's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 was 17.26%.


Bioptik Technology Gross-Profit-to-Asset % Historical Data

The historical data trend for Bioptik Technology's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioptik Technology Gross-Profit-to-Asset % Chart

Bioptik Technology Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.49 10.91 11.68 15.90 17.95

Bioptik Technology Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.09 18.30 17.15 20.41 17.26

Competitive Comparison of Bioptik Technology's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Bioptik Technology's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioptik Technology's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioptik Technology's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Bioptik Technology's Gross-Profit-to-Asset % falls into.


;
;

Bioptik Technology Gross-Profit-to-Asset % Calculation

Bioptik Technology's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=267.905/( (1497.706+1487.743)/ 2 )
=267.905/1492.7245
=17.95 %

Bioptik Technology's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=255.228/( (1487.743+1469.235)/ 2 )
=255.228/1478.489
=17.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Bioptik Technology Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Bioptik Technology's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioptik Technology Business Description

Traded in Other Exchanges
N/A
Address
No.188, Zhonghua South Road, Miaoli County, Zhunan, TWN, 35057
Bioptik Technology Inc is a Taiwan-based company engaged in the research, development, production, and sale of medical devices and reagents. The company is also focused on developing skin care products and aims to engage in developing bioenergy, Astaxanthin, and Cellulose Bioethanol. It is involved in the business areas of Home care medical devices, Skincare- Its own brand, Dietary supplement OEM and ODM, Skincare- OEM and ODM, and Biodiesel. In the Home care business area, the company provides Easy Touch blood glucose monitoring, and blood cholesterol and uric acid monitoring systems, as well as its strips.

Bioptik Technology Headlines

No Headlines